These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 31118599)

  • 1. Survival associated with chronic obstructive pulmonary disease among SEER-Medicare beneficiaries with non-small-cell lung cancer.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    Int J Chron Obstruct Pulmon Dis; 2019; 14():893-903. PubMed ID: 31118599
    [No Abstract]   [Full Text] [Related]  

  • 2. Healthcare utilization and costs associated with COPD among SEER-Medicare beneficiaries with NSCLC.
    Shah S; Blanchette CM; Coyle JC; Kowalkowski M; Arthur ST; Howden R
    J Med Econ; 2018 Sep; 21(9):861-868. PubMed ID: 29857784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
    Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
    Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of clinical characteristics and overall survival between spirometrically diagnosed chronic obstructive pulmonary disease (COPD) and non-COPD never-smoking stage I-IV non-small cell lung cancer patients.
    Lim JU; Yeo CD; Rhee CK; Kang HS; Park CK; Kim JS; Kim JW; Kim SJ; Yoon HK; Lee SH
    Int J Chron Obstruct Pulmon Dis; 2019; 14():929-938. PubMed ID: 31118602
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between chronic obstructive pulmonary disease and non-small cell lung cancer in the elderly.
    Wang P; Zhu M; Zhang D; Guo XG; Zhao S; Zhang XL; Wang DL; Liu CT
    Cancer Med; 2019 Aug; 8(9):4124-4134. PubMed ID: 31184445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient characteristics, treatment patterns, and health outcomes among COPD phenotypes.
    Allen-Ramey FC; Gupta S; DiBonaventura MD
    Int J Chron Obstruct Pulmon Dis; 2012; 7():779-87. PubMed ID: 23226014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COPD is commonly underdiagnosed in patients with lung cancer: results from the RECOIL study (retrospective study of COPD infradiagnosis in lung cancer).
    Parrón Collar D; Pazos Guerra M; Rodriguez P; Gotera C; Mahíllo-Fernández I; Peces-Barba G; Seijo LM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():1033-1038. PubMed ID: 28408813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.
    Pasquale MK; Sun SX; Song F; Hartnett HJ; Stemkowski SA
    Int J Chron Obstruct Pulmon Dis; 2012; 7():757-64. PubMed ID: 23152680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mortality in COPD patients according to clinical phenotypes.
    Golpe R; Suárez-Valor M; Martín-Robles I; Sanjuán-López P; Cano-Jiménez E; Castro-Añón O; Pérez de Llano LA
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1433-1439. PubMed ID: 29750029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity.
    Wang W; Dou S; Dong W; Xie M; Cui L; Zheng C; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2018; 13():3767-3776. PubMed ID: 30538439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between asthma, chronic bronchitis, emphysema, chronic obstructive pulmonary disease, and lung cancer in the US population.
    Rahman HH; Niemann D; Munson-McGee SH
    Environ Sci Pollut Res Int; 2023 Feb; 30(8):20147-20158. PubMed ID: 36251191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of chronic obstructive pulmonary disease on the mortality of patients with non-small-cell lung cancer.
    Lee SJ; Lee J; Park YS; Lee CH; Lee SM; Yim JJ; Yoo CG; Han SK; Kim YW
    J Thorac Oncol; 2014 Jun; 9(6):812-7. PubMed ID: 24807154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of COPD on symptoms, quality of life and prognosis in patients with advanced non-small cell lung cancer.
    Yi YS; Ban WH; Sohng KY
    BMC Cancer; 2018 Oct; 18(1):1053. PubMed ID: 30373585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of coexisting COPD on survival of patients with early-stage non-small cell lung cancer undergoing surgical resection.
    Zhai R; Yu X; Shafer A; Wain JC; Christiani DC
    Chest; 2014 Feb; 145(2):346-353. PubMed ID: 24008835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining COPD with clinical, pathological and demographic information refines prognosis and treatment response prediction of non-small cell lung cancer.
    Putila J; Guo NL
    PLoS One; 2014; 9(6):e100994. PubMed ID: 24967586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of emphysema and airway obstruction in prognosis of lung cancer.
    Gullón JA; Suárez I; Medina A; Rubinos G; Fernández R; González I
    Lung Cancer; 2011 Feb; 71(2):182-5. PubMed ID: 20554345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of severe-to-very severe chronic obstructive pulmonary disease on the prognosis of patients with non-small cell lung cancer who received chemotherapy.
    Dong W; Zhu Y; Du Y; Wang L; Feng X; Ma S
    Clin Respir J; 2020 Apr; 14(4):345-352. PubMed ID: 31876095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of survival of chronic obstructive pulmonary disease patients with or without a localized non-small cell lung cancer.
    Jeppesen SS; Hansen NG; Schytte T; Nielsen M; Hansen O
    Lung Cancer; 2016 Oct; 100():90-95. PubMed ID: 27597286
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Geographic variations of the prevalence and distribution of COPD phenotypes in Spain: "the ESPIRAL-ES study".
    Alcázar-Navarrete B; Trigueros JA; Riesco JA; Campuzano A; Pérez J
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1115-1124. PubMed ID: 29692606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study.
    Husebø GR; Nielsen R; Hardie J; Bakke PS; Lerner L; D'Alessandro-Gabazza C; Gyuris J; Gabazza E; Aukrust P; Eagan T
    Respir Med; 2019 Jun; 152():81-88. PubMed ID: 31128615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.